首页 > 市场调查报告书 > 医疗设备

眼科设备

市场调查报告书

商品编码

1654666

全球角膜移植市场 - 2025 - 2033

Global Corneal Transplant Market - 2025-2033

出版日期: 2025年02月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球角膜移植市场规模达到 5.2388 亿美元，预计到 2033 年将达到 10069.5 亿美元，2025-2033 年预测期内的复合年增长率为 7.59%。

角膜移植，也称为角膜移植术，是一种外科手术，用捐赠的角膜替换受损或患病的角膜，以恢復视力并改善眼睛健康。角膜是眼睛前部的透明圆顶状层，它的健康对于正常视力至关重要。当圆锥角膜、角膜营养不良、角膜瘢痕和感染等情况导致严重视力障碍或失明时，通常会进行角膜移植。根据角膜损伤的程度，此手术可以涉及全层移植（穿透性角膜移植）或部分层移植（板层角膜移植）。

雷射辅助和微创手术等手术技术的进步显着改善了角膜移植的效果，缩短了恢復时间并提高了移植存活率。

市场动态：

驱动因素与约束因素

角膜疾病和眼部疾病数量不断增加

角膜疾病和眼部疾病的数量不断增加是推动角膜移植需求的主要因素。圆锥角膜、角膜营养不良、感染和疤痕等病症变得越来越常见，这增加了透过移植来恢復视力的需求。例如，根据美国国立卫生研究院 2022 年的数据，圆锥角膜影响了中东等少数地区约 5% 的人口。

这些情况会导致严重的视力问题甚至失明，迫使许多患者寻求角膜移植作为解决方案。这些疾病的发生率在年轻人中尤其明显，圆锥角膜等疾病影响着许多十几岁或二十几岁的年轻人。

由于多种因素，全球范围内角膜移植的发生率不断增加。随着这种增长，各机构和诊所正在执行这些程序以满足不断增长的需求。例如，过去35年来，LVPEI（LV普拉萨德眼科研究所）已成功取得了超过120,000个角膜，成为亚太地区最大的角膜捐赠计画。目前，该研究所每年可摘取超过12,000枚角膜，为提供可供移植的捐赠角膜做出了重大贡献。预计这些程序的增加将增加对手术所需设备和套件的需求，从而进一步促进市场的成长。

角膜移植相关併发症

与角膜移植相关的併发症和风险可能会使患者和医疗专业人员感到沮丧，从而阻碍市场的成长。虽然角膜移植通常是成功的，但仍有诸如移植排斥、感染和角膜肿胀等潜在问题，可能导致移植失败。这些问题可能需要额外的手术或长期用药来防止排斥，从而使恢復过程复杂化，这可能会导致移植的采用速度变慢并影响市场的扩张。

CorneaGen
Ziemer Ophthalmic Systems AG
RUMEX International Co.
CorNeat Vision
KeraMed, Inc.
Corza Ophthalmology
Inami & CO.,Ltd
Leica Microsystems
Surtex Instruments Limited.
Similar data will be provided for each market player.
Processa 製药公司
- 管道产品描述
- 产品关键绩效指标 (KPI)
- 主要活动
- 市场进入时间表
- 产品渗透率
- 销售估计和预测
Vanda 製药公司
Renexxion 爱尔兰有限公司
Aclipse治疗公司
将为每个市场参与者提供类似的资料。

第 15 章：附录

简介目录

Product Code: PH9100

The global corneal transplant market reached US$ 523.88 million in 2024 and is expected to reach US$ 1,006.95 billion by 2033, growing at a CAGR of 7.59% during the forecast period 2025-2033.

Corneal transplant, also known as keratoplasty, is a surgical procedure in which a damaged or diseased cornea is replaced with a donor cornea to restore vision and improve eye health. The cornea is the transparent, dome-shaped layer at the front of the eye, and its health is crucial for proper vision. Corneal transplants are typically performed when conditions such as keratoconus, corneal dystrophies, corneal scarring, and infection lead to significant vision impairment or blindness. The procedure can involve either full-thickness transplants (penetrating keratoplasty) or partial-thickness transplants (lamellar keratoplasty), depending on the extent of the corneal damage.

Advancements in surgical techniques, such as laser-assisted and minimally invasive procedures, have significantly improved the outcomes of corneal transplants, reducing recovery times and increasing graft survival rates.

Market Dynamics: Drivers & Restraints

Growing number of corneal diseases and eye disorders

The growing number of corneal diseases and eye disorders is a major factor driving the demand for Corneal Transplants. Conditions like keratoconus, corneal dystrophies, infections, and scarring are becoming more common, which is increasing the need for transplants as a way to restore vision. For instance, according to the National Institute of Health in 2022, keratoconus affects about 5% of the population in few regions, Middle East.

These conditions can cause serious vision problems and even blindness, pushing many patients to seek corneal transplants as a solution. The rise in these disorders is particularly noticeable among younger people, with conditions like keratoconus affecting many in their teens or twenties.

There is a growing incidnce of corneal transplantations across the globe due to several factors. With this growth, the institutes and clinics are performing these procedures to meet the rising demand. For instance, Over the past 35 years, LVPEI (L V Prasad Eye Institute) has successfully harvested more than 120,000 corneas, making it the largest corneal donation program in the Asia-Pacific region. Currently, the institute is able to harvest over 12,000 corneas annually, contributing significantly to the availability of donor corneas for transplantation. This increasing procedures is expected to increase the demand for the devices and kits required for performing, further contributing to the growing market.

Complications associated with corneal transplantation

Complications and risks associated with Corneal Transplants could hold back the market's growth by discouraging both patients and healthcare professionals. Although corneal transplants are generally successful, there are still potential issues like graft rejection, infections, and corneal swelling that could cause the transplant to fail. These problems might require extra surgeries or long-term medication to prevent rejection, complicating the recovery process, which may lead to slower adoption of transplants and impact the market's expansion.

Segment Analysis

The global corneal transplant market is segmented based on procedure type, device type, surgery type, indication, end-user, and region.

Treatment:

Microsurgical instruments segment is expected to dominate the global corneal transplant market share

The microsurgical instruments segment is expected to hold a dominant position in the corneal transplant market due to the significant role these specialized tools play in the success of corneal transplant surgeries. Corneal transplant procedures are highly delicate and require precise, minimally invasive techniques to ensure proper graft placement and reduce the risk of complications. Microsurgical instruments, such as fine forceps, micro scissors, and laser-assisted tools, allow surgeons to perform these intricate surgeries with exceptional precision and control.

As advancements in surgical techniques continue, microsurgical instruments are becoming more sophisticated, improving outcomes, and reducing recovery times for patients. This advanced features are creating a high demand for these devices. Several market players are increasing developing advanced m,icrosurgical instruments to perform penetrating keratoplasty (full-thickness transplants) and lamellar keratoplasty (partial-thickness transplants), which require extremely fine and accurate cuts to minimize tissue damage and enhance graft survival.

With the increasing number of corneal transplants being performed globally, the demand for advanced microsurgical instruments is growing, as they are integral to ensuring the safety and success of these procedures.

Geographical Analysis

North America is expected to hold a significant position in the global corneal transplant market share

North America is expected to maintain a leading position in the global corneal transplant market for several key reasons. The region's advanced healthcare infrastructure, high awareness of eye health, and access to cutting-edge medical technologies all play a major role. Both the United States and Canada have well-established healthcare systems with top-tier medical facilities and highly skilled ophthalmologists, making them leaders in performing complex corneal transplants. This expertise ensures high success rates, making North America a go-to destination for corneal transplants.

The growing prevalence of corneal diseases like keratoconus and corneal dystrophies, along with an aging population more prone to eye conditions, is also driving demand for corneal transplants in the region. For instance, according to the publication by the National Institute of Health in 2024, in the United States, the estimated prevalence of Fuchs' Endothelial Corneal Dystrophy (FECD) among individuals over the age of 65 is 1.12%. The condition is notably more common in women and the White population compared to other ethnic groups.

Moreover, continuous advancements in surgical techniques as well as innovations in artificial corneas and stem cell therapies, are strengthening North America's position in the market. For instance, in June 2024, CorneaGen launched Corneal Tissue Addition for Keratoplasty (CTAK), an innovative and extremely effective solution to corneal contouring for keratoconic eyes.

The region's ongoing investment in research and development in ophthalmology continues to improve transplant outcomes, reducing recovery times and increasing success rates. These factors all contribute to North America's dominant role in the global corneal transplant market.

Competitive Landscape

The major global players in the corneal transplant market include Carl Zeiss AG, CorneaGen, Ziemer Ophthalmic Systems AG, RUMEX International Co., CorNeat Vision, KeraMed, Inc., Corza Ophthalmology, Inami & CO., Ltd, Leica Microsystems and Surtex Instruments Limited. among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Corneal Transplant Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Procedure Type
3.2. Snippet by Device Type
3.3. Snippet by Type
3.4. Snippet by Surgery Type
3.5. Snippet by Indication
3.6. Snippet by End-User
3.7. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing number of corneal diseases and eye disorders
- 4.1.2. Restraints
  - 4.1.2.1. Complications associated with the corneal transplantation
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Procedure Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
- 6.1.2. Market Attractiveness Index, By Procedure Type
6.2. Endothelial Keratoplasty*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Penetrating Keratoplasty
6.4. Anterior Lamellar Keratoplasty (ALK)
6.5. Corneal Limbal Stem Cell Transplant
6.6. Artificial Corneal Transplant
6.7. Others

7. By Device Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 7.1.2. Market Attractiveness Index, By Device Type
7.2. Microsurgical Instruments*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Microkeratome
7.4. Optical Coherence Tomography (OCT)
7.5. Artificial Corneas
7.6. Others

8. By Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 8.1.2. Market Attractiveness Index, By Type
8.2. Human Cornea*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Synthetic

9. By Surgery Type

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
- 9.1.2. Market Attractiveness Index, By Surgery Type
9.2. Conventional Surgery*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Laser-Assisted Surgery

10. By Indication

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 10.1.2. Market Attractiveness Index, By Indication
10.2. Fuch's Endothelial Dystrophy*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Infectious Keratitis
10.4. Bullous Keratopathy
10.5. Keratoconus
10.6. Regraft Procedures
10.7. Corneal Scarring
10.8. Corneal Ulcers
10.9. Others

11. By End-User

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.1.2. Market Attractiveness Index, By End-User
11.2. Hospitals*
- 11.2.1. Introduction
- 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Ophthalmic Clinics
11.4. Others

12. By Region

12.1. Introduction
- 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 12.1.2. Market Attractiveness Index, By Region
12.2. North America
- 12.2.1. Introduction
- 12.2.2. Key Region-Specific Dynamics
- 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
- 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
- 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.2.9.1. U.S.
  - 12.2.9.2. Canada
  - 12.2.9.3. Mexico
12.3. Europe
- 12.3.1. Introduction
- 12.3.2. Key Region-Specific Dynamics
- 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
- 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
- 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.3.9.1. Germany
  - 12.3.9.2. U.K.
  - 12.3.9.3. France
  - 12.3.9.4. Spain
  - 12.3.9.5. Italy
  - 12.3.9.6. Rest of Europe
12.4. South America
- 12.4.1. Introduction
- 12.4.2. Key Region-Specific Dynamics
- 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
- 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
- 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.4.9.1. Brazil
  - 12.4.9.2. Argentina
  - 12.4.9.3. Rest of South America
12.5. Asia-Pacific
- 12.5.1. Introduction
- 12.5.2. Key Region-Specific Dynamics
- 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
- 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
- 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.5.9.1. China
  - 12.5.9.2. India
  - 12.5.9.3. Japan
  - 12.5.9.4. South Korea
  - 12.5.9.5. Rest of Asia-Pacific
12.6. Middle East and Africa
- 12.6.1. Introduction
- 12.6.2. Key Region-Specific Dynamics
- 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
- 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
- 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 12.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. Company Profiles

Key Market Players

14.1. Carl Zeiss AG*
- 14.1.1. Company Overview
- 14.1.2. Product Portfolio
  - 14.1.2.1. Product Description
  - 14.1.2.2. Product Key Performance Indicators (KPIs)
  - 14.1.2.3. Historic and Forecasted Product Sales
  - 14.1.2.4. Product Sales Volume
- 14.1.3. Financial Overview
  - 14.1.3.1. Company Revenue's
  - 14.1.3.2. Geographical Revenue Shares
  - 14.1.3.3. Revenue Forecasts
- 14.1.4. Key Developments
  - 14.1.4.1. Mergers & Acquisitions
  - 14.1.4.2. Key Product Development Activities
  - 14.1.4.3. Regulatory Approvals etc.
- 14.1.5. SWOT Analysis
14.2. CorneaGen
14.3. Ziemer Ophthalmic Systems AG
14.4. RUMEX International Co.
14.5. CorNeat Vision
14.6. KeraMed, Inc.
14.7. Corza Ophthalmology
14.8. Inami & CO.,Ltd
14.9. Leica Microsystems
14.10. Surtex Instruments Limited.
Similar data will be provided for each market player.

Emerging Market Players

14.11. Processa Pharmaceuticals, Inc.*
- 14.11.1. Pipeline Products Description
- 14.11.2. Product Key Performance Indicators (KPIs)
- 14.11.3. Key Activities
- 14.11.4. Market Entry Timelines
- 14.11.5. Product Penetration Rate
- 14.11.6. Sales Estimation and Projections
14.12. Vanda Pharmaceuticals Inc.
14.13. Renexxion Ireland Limited
14.14. Aclipse Therapeutics
Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE